Mark G. Glaser
Impact in
Papers in
- Co-authors
- Edward S. Newlands (5 shared papers)Iain R. Colquhoun (3 shared papers)Stephen R. Wedge (2 shared papers)Colin Brock (4 shared papers)Mark Bower (3 shared papers)Helen S Evans (3 shared papers)Paul D. Lewis (4 shared papers)Susan M. O'Reilly (2 shared papers)
- Journals
- Clinical Oncology (9 papers)Clinical Radiology (3 papers)Journal of the Royal Society of Medicine (2 papers)European Journal of Cancer (2 papers)Cancer (2 papers)
- Partner nations
- United KingdomGermanyUnited States
In The Last Decade
Mark G. Glaser
36 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 88
- Genetics 735
- Neurology 397
- Pathology and Forensic Medicine 252
- Pulmonary and Respiratory Medicine 337
- Cancer Research 127
Countries citing papers authored by Mark G. Glaser
This map shows the geographic impact of Mark G. Glaser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark G. Glaser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark G. Glaser more than expected).
Fields of papers citing papers by Mark G. Glaser
This network shows the impact of papers produced by Mark G. Glaser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark G. Glaser. The network helps show where Mark G. Glaser may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark G. Glaser, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 36 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Phase I trial of temozolomide using an extended continuous oral schedule. | 1998 | 249 |
| 2 | 1993 | 238 | |
| 3 | A medical research council randomized trial in patients with primary cerebral non-Hodgkin lymphoma: cerebral radiotherapy with and without cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy. | 2000 | 162 |
| 4 | 2000 | 148 | |
| 5 | 1996 | 139 | |
| 6 | 1997 | 124 | |
| 7 | 1999 | 57 | |
| 8 | 1999 | 55 | |
| 9 | 2006 | 38 | |
| 10 | Synthesis and anticancer activity of nordihydroguaiaretic acid (NDGA) and analogues. | 2001 | 36 |
| 11 | 1983 | 26 | |
| 12 | 1992 | 26 | |
| 13 | A study of the effects of radiation on prevention of gynaecomastia due to oestrogen therapy. | 1979 | 19 |
| 14 | 1995 | 18 | |
| 15 | 1982 | 18 | |
| 16 | 2010 | 17 | |
| 17 | 1990 | 15 | |
| 18 | 1981 | 14 | |
| 19 | 1989 | 12 | |
| 20 | 1989 | 12 |
About Mark G. Glaser
Mark G. Glaser is a scholar working on Genetics, Neurology, Pulmonary and Respiratory Medicine, Otorhinolaryngology and Oncology, having authored 36 papers that have together received 1.5k indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (12 papers), CNS Lymphoma Diagnosis and Treatment (6 papers), Brain Metastases and Treatment (5 papers), Head and Neck Cancer Studies (4 papers), Neuroblastoma Research and Treatments (4 papers), Medical Imaging and Pathology Studies (3 papers), Head and Neck Surgical Oncology (3 papers) and Management of metastatic bone disease (2 papers). The work is most often cited by research in Genetics (735 citations), Neurology (397 citations), Pathology and Forensic Medicine (252 citations), Pulmonary and Respiratory Medicine (337 citations) and Cancer Research (127 citations). Mark G. Glaser has collaborated with scholars based in United Kingdom, Germany and United States. Frequent co-authors include Edward S. Newlands, Iain R. Colquhoun, Stephen R. Wedge, Colin Brock, Mark Bower, Helen S Evans, Paul D. Lewis, Susan M. O'Reilly, Peter G. Richards and Robin D. Illingworth. Their work appears in journals such as Clinical Oncology, Clinical Radiology, Journal of the Royal Society of Medicine, European Journal of Cancer and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.